Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.69 |
| ▸ | RAD52 | P43351 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27766562 | 1.00 | NAAA (0.69) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL6561692 | 1.00 | NAAA (0.69) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL20067027 | 0.98 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL11125285 | 0.98 | NAAA (0.65) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5448501 | 0.98 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1548190 | 0.98 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL4332027 | 0.98 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5696640 | 0.98 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5440890 | 0.98 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL95547 | 0.98 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917973-A1 | Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof | Teva Pharmaceutical Industries Ltd (IL) | 2008-05-07 | — | — | EP | claimed |
| EP-1864677-B1 | Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof | TEVA PHARMA (IL) | 2008-01-02 | — | — | EP | claimed |
| EP-1864677-A1 | Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof | Teva Pharmaceutical Industries Ltd (IL) | 2007-12-12 | — | — | EP | claimed |
| CN-118829416-A | Composition (III) | 西姆莱斯股份公司 | 2024-10-22 | — | — | CN | disclosed |
| EP-2395838-B1 | STABLE PHARMACEUTICAL COMPOSITION FOR ATHEROSCLEROSIS | CADILA PHARMACEUTICALS LTD (IN) | 2018-07-25 | — | — | EP | disclosed |
| US-9789187-B2 | Stable pharmaceutical composition for atherosclerosis | CADILA PHARMACEUTICALS LIMITED (IN) | 2017-10-17 | — | — | US | disclosed |
| US-20120027849-A1 | STABLE PHARMACEUTICAL COMPOSITION FOR ATHEROSCLEROSIS | CADILA PHARMACEUTICALS LIMITED (IN) | 2012-02-02 | — | — | US | disclosed |
| EP-1917973-A1 | Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof | Teva Pharmaceutical Industries Ltd (IL) | 2008-05-07 | — | — | EP | disclosed |
| EP-1864677-B1 | Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof | TEVA PHARMA (IL) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007142628-A1 | STABLE FORMULATION COMPRISING MOISTURE SENSITIVE DRUG/S AND MANUFACTURING PROCEDURE THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-12-13 | — | — | WO | disclosed |
| EP-1864677-A1 | Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof | Teva Pharmaceutical Industries Ltd (IL) | 2007-12-12 | — | — | EP | disclosed |
| US-20070281000-A1 | Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-12-06 | — | — | US | disclosed |